Please wait...
About This Project
An estimated 6 β 7 million people in Latin America and 300,000 U.S. citizens are infected with the protozoan parasite Trypanosoma cruzi that results in Chagasβ disease, a neglected tropical disease (NTD). Principally spread by the kissing bug (cover image), there exists an urgent need for development of new therapeutics to replace the outdated clinically used drugs, benznidazole and nifurtimox. Our research focuses on the discovery of novel antichagasic compounds for improved medicine.
Browse Other Projects on Experiment
Related Projects
Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection
We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...
Mathematical model to reduce maternal and infant mortality in Southeast Asia
Maternal and child mortality in Southeast Asian countries is still very high, especially in poor and rural...
Can plant-based antimicrobials act as an alternative to therapeutic antibiotics?
Antibiotic overuse has led to antimicrobial resistance (AMR). The World Health Organisation (WHO) ranks...